Late in 2022, the United States Pharmacopeia (USP) released its final revisions to General Chapter <797> Pharmaceutical Compounding – Sterile Preparations.
The revision, which becomes official November 1, 2023, represents a significant change from the 2008 standards currently in use.
Compounding pharmacies must respond to the new standards and requirements by:
Understanding the new compounded sterile preparation (CSP) category definitions and updating beyond-use dates (BUDs) for each
– Conducting role-based personnel training and evaluations
– Updating microbiological air and surface monitoring practices
– Effectively communicating new standards for cleaning tasks, frequencies, and agents
– Redefining the designated person(s) role and quality program
– Complying with new documentation requirements
A recent Wolters Kluwer webinar comprehensively walked through the most important of these changes and offered implementation suggestions for each. This article will give you a sense of just how demanding this will be by diving into one of the most critical new requirements – personnel training and competency. Read more >
